248 related articles for article (PubMed ID: 17671694)
1. Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
Cai G; Wang J; Xin X; Ke Z; Luo J
Int J Oncol; 2007 Sep; 31(3):657-62. PubMed ID: 17671694
[TBL] [Abstract][Full Text] [Related]
2. Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.
Park CH; Lee BH; Ahn SG; Yoon JH; Oh SH
Toxicol Sci; 2013 Oct; 135(2):380-9. PubMed ID: 23897984
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
4. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
Cao Q; Feng YJ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
[TBL] [Abstract][Full Text] [Related]
5. GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.
Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Cadoret A; Capeau J; Desbois-Mouthon C
Int J Oncol; 2005 Jul; 27(1):215-22. PubMed ID: 15942663
[TBL] [Abstract][Full Text] [Related]
6. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.
Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Ruiz-Ruiz C; Cadoret A; Capeau J; Desbois-Mouthon C
Exp Cell Res; 2004 Nov; 300(2):354-64. PubMed ID: 15475000
[TBL] [Abstract][Full Text] [Related]
7. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
8. Expression of endometrial glycogen synthase kinase-3beta protein throughout the menstrual cycle and its regulation by progesterone.
Salameh W; Helliwell JP; Han G; McPhaul L; Khorram O
Mol Hum Reprod; 2006 Sep; 12(9):543-9. PubMed ID: 16882987
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
10. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
Menon B; Johnson JN; Ross RS; Singh M; Singh K
J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
[TBL] [Abstract][Full Text] [Related]
12. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
Yu AS; Zhao L
Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575
[TBL] [Abstract][Full Text] [Related]
13. Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3beta phosphorylation and coupling with 14-3-3.
Mwangi S; Anitha M; Fu H; Sitaraman SV; Srinivasan S
Neuroscience; 2006 Nov; 143(1):241-51. PubMed ID: 16996218
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells.
Kim Y; Lee YI; Seo M; Kim SY; Lee JE; Youn HD; Kim YS; Juhnn YS
J Neurochem; 2009 Oct; 111(2):344-54. PubMed ID: 19659461
[TBL] [Abstract][Full Text] [Related]
15. Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.
Kirshenboim N; Plotkin B; Shlomo SB; Kaidanovich-Beilin O; Eldar-Finkelman H
J Mol Neurosci; 2004; 24(2):237-45. PubMed ID: 15456937
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
17. Prolonged wild-type p53 protein accumulation and cisplatin resistance.
Yazlovitskaya EM; DeHaan RD; Persons DL
Biochem Biophys Res Commun; 2001 May; 283(4):732-7. PubMed ID: 11350044
[TBL] [Abstract][Full Text] [Related]
18. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells.
Lee YI; Seo M; Kim Y; Kim SY; Kang UG; Kim YS; Juhnn YS
J Biol Chem; 2005 Jun; 280(23):22044-52. PubMed ID: 15799972
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
Cao Q; Lu X; Feng YJ
Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
